In particular, lack of CtsK function was associated to bone-related conditions such as osteopetrosis and the autosomal recessive gene disorder, pycnodysostosis [18], whereas overexpression of CtsK was reported in metastatic cancer cells [19–23]. Here, CTSK is linked to metastatic malignant neoplasm.